Sawai Group Holdings Co., Ltd. (SWGHF)

USD 13.4

(0.0%)

Market Cap (In USD)

1.76 Billion

Revenue (In USD)

176.86 Billion

Net Income (In USD)

13.69 Billion

Avg. Volume

79.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.0-40.2
PE
-
EPS
-
Beta Value
0.176
ISIN
JP3323040000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Mitsuo Sawai
Employee Count
-
Website
https://www.sawaigroup.holdings
Ipo Date
2021-11-09
Details
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, granules, capsules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, chemotherapeutic agents, etc., as well as vitamin preparations. It sells its generic drugs to distributors, wholesalers, and retailers in Japan and the United States. The company was founded in 1929 and is headquartered in Osaka, Japan.